Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-20

Clinical Trial Update: Tradipitant for Functional Dyspepsia [Phase 2]

View source ↗

Summary

Phase 2 trial update for tradipitant in functional dyspepsia, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tradipitant (tradipitant)

Snippet

Sponsor: Xiao Jing (Iris) Wang | Conditions: Functional Dyspepsia | Phase 2 | Status: ENROLLING_BY_INVITATION